IMC Chicago’s Ionis Pharmaceuticals IONS Stock Holding History

IMC Chicago’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.19M	Sell	71,400 -53,500	-43%	-$3.04M	﹤0.01%	2688
2026 Q2	$9.9M	Buy	124,900 +97,400	+354%	+$7.33M	﹤0.01%	1548
2026 Q1	$2.06M	Buy	27,500 +12,600	+85%	+$994K	﹤0.01%	2540
2025 Q4	$1.18M	Buy	14,900 +1,400	+10%	+$105K	﹤0.01%	2852
2025 Q3	$883K	Buy	+13,500	New	+$659K	﹤0.01%	2806

Other funds holding IONS

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

IMC Chicago's IONS Position: Q3 2026 in Review

IMC Chicago opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 25,075 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #3773 among its holdings.

194 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

IMC Chicago held 25,075 shares of Ionis Pharmaceuticals worth $1.12M as of Q3 2026.
Ionis Pharmaceuticals was a new IMC Chicago position in Q3 2026.
Ionis Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #3773 holding.
194 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.